AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00622752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EVT 302, 10 mg
Description: 2 X EVT 302, 5 mg tablets
Study NCT00622752 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 2 X placebo tablets to match EVT 302 5 mg
Study NCT00622752 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy (NRT)
Description: NRT patch containing 21 mg of nicotine
Study NCT00622752 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: NRT placebo
Description: Medically inert plaster cut to match the NRT plaster
Study NCT01326611 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clarithromycin
Study NCT01326611 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dextrose
Study NCT05167994 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib hydrochloride
Description: Anlotinib 12mgQD, from D1 of pre-operative IMRT to 1 month after end of IMRT
Study NCT02626273 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: weight loss
Study NCT02626273 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: weight loss
Study NCT02457780 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relaxation Response Resiliency Program (3RP)
Description: The 3RP is designed to decrease psychiatric and physical health symptoms and build resiliency by teaching skills to (1) elicit the relaxation response, (2) decrease stress reactivity and (3) increase social connectedness. Eliciting the relaxation response involves sustained mental focus with an attitude of receptive awareness with strategies aimed at reducing muscle tension, breathing rate, heart rate, and blood pressure. Decreasing stress reactivity involves increasing awareness of the stress response and learning skills to proactively address stress. Increasing connectedness involves skills to promote positive growth, self-efficacy and social support. Other skills and experiential exercises focus on increasing acceptance, optimism, empathy, and appreciation to promote resiliency.
Study NCT02457780 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Health Enhancement Program (HEP)
Description: The HEP is designed to address comorbid physical and mental health symptoms via psychoeducation, self-monitoring and goal setting techniques. It is an 8 session manualized group intervention which addresses topics including sleep hygiene, nutrition, exercise, working with a healthcare team, and substance use. The program uses a variety of in-session activities to engage participants in discussion related to self-care and wellness principles. Relapse prevention and long-term goal setting are addressed. The program is designed to be implemented by professionals with a background in mental health.
Study NCT04059848 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: tDCS(Intelect Mobile Stimulation and Combination, DJO, France)
Study NCT04059848 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: tDCS(Intelect Mobile Stimulation and Combination, DJO, France)
Study NCT04059848 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: SHAM_COMPARATOR
Intervention: NMES(Enraf Nonius, Endomed-182, Netherlands)
Study NCT04059848 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: NMES(Enraf Nonius, Endomed-182, Netherlands)
Study NCT04059848 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: NMES(Enraf Nonius, Endomed-182, Netherlands)
Study NCT01561768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novavax Quadrivalent vaccine
Description: Quadrivalent VLP vaccine: low dose; intramuscular injection, deltoid
Study NCT01561768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novavax Quadrivalent vaccine
Description: Quadrivalent VLP vaccine: medium dose; intramuscular injection, deltoid
Study NCT01561768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novavax Quadrivalent vaccine
Description: Quadrivalent VLP vaccine: high dose; intramuscular injection, deltoid
Study NCT01561768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novavax Trivalent vaccine
Description: Trivalent Dose; intramuscular injection, deltoid
Study NCT01561768 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: cTIV
Description: Preconfigured dose; intramuscular injection, deltoid
Study NCT00892970 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azithromycin ophthalmic solution, 1%
Description: One drop in each eye twice a day for the first two days; then one drop in each eye once a day for 12 days
Study NCT00892970 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One drop in each eye twice a day for the first two days; then one drop in each eye once a day for 12 days
Study NCT04270500 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Prehabilitation program
Description: The preoperative period (prehabilitation) represents a more appropriate time than the postoperative period to implement an intervention. Prehabilitation is a process of enhancing an individual's functional capacity before the scheduled surgery, aimed at improving the patient's tolerance to upcoming physiologic stress, by three principal elements: exercise training, nutritional intervention, and psychological support.
Study NCT00855309 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: acyclovir sodium
Description: Given IV
Study NCT04086264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Commercially available formulation given subcutaneously (SC) or intravenous (IV)
Study NCT04086264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMGN632
Description: Study formulation given intravenously (IV)
Study NCT04086264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Commercially available formulation administered orally
Study NCT03904771 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition counselling + peer support
Description: Behavioral nutrition counselling and peer support, delivered in small groups. Includes six sessions extending over 8 weeks, with participatory activities facilitated by a nutrition therapist.
Study NCT03904771 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social activation + peer support
Description: Social activation and peer support, delivered in small groups. Includes six sessions extending over 8 weeks, with participatory activities facilitated by group leader.
Study NCT03732911 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Participants will receive the following intervention bundle (1) educational materials about child development and developmental monitoring checklists; (2) age and language appropriate picture books; and (3) two tailored text messages per week for a 6-month period.
Study NCT03671902 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Fluid shift
Description: We are using lower body negative and positive pressure to create a fluid shift in the body. This study is investigating if there are changes in phonocardiographic parameters related to changes in blood volume caused by this fluid shift
Study NCT01120210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-39588146 5 ng/kg/min
Description: 1-hour infusion of JNJ-39588146 5 ng/kg/min on Day 1
Study NCT01120210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-39588146 15 ng/kg/min
Description: 1-hour infusion of JNJ-39588146 15 ng/kg/min on Day 1
Study NCT01120210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-39588146 30 ng/kg/min
Description: 1-hour infusion of JNJ-39588146 30 ng/kg/min on Day 1
Study NCT01120210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: 1-hour infusion of matching placebo on Day 1
Study NCT01120210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-39588146 5, 15, or 30 ng/kg/min
Description: 18-hour infusion of JNJ-39588146 or matching placebo on Day 1 immediately folllowing the 3-hour infusion at a dose equal to the maximum dose tolerated by that patient during the 3-hour infusion in Part 1 of the study.
Study NCT04296396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0 to 20 tablets of oxycodone 5mg
Description: Individualized opioid prescription protocol (IOPP) that includes shared decision making
Study NCT04296396 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Fixed opioid prescription
Description: 20 tablets of oxycodone 5mg
Study NCT02752295 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: stress-coping week
Description: The multidisciplinary team will offer Mindfulness-Based Stress Reduction (MBSR), group psychotherapy (resilience, Cognitive Behavioral Analysis System of Psychotherapy CBASP, psychodynamic therapy), relaxation training, nutrition course, stress-coping and physical training in a group setting.
Study NCT02752295 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: additional two days follow-up weekend
Description: A two-days follow-up which recapitulates previous treatment elements.
Study NCT02269891 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nu Femme
Description: Combination product of Labisia pumila and Eurycoma longifolia extracts
Study NCT02269891 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04546958 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Whey protein supplements
Description: Nutritional counseling and whey protein supplements for 3 months
Study NCT04546958 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional counseling
Description: Nutritional counseling by dietitians for 3 months
Study NCT04546958 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional counseling
Description: Nutritional counseling by dietitians for 3 months
Study NCT04285983 — intervention group
Intervention type: DRUG
Intervention: Trelagliptin
Description: Trelagliptin tablets
Study NCT00006001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: semaxanib
Study NCT01620749 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 18F MEL050
Description: Diagnostic intervention to establish the safety and biodistribution of MEL050 in participants with melanoma.
Study NCT05278117 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: outcomes of complete burst abdomen repair using posterior component separation technique with transversus abdominis muscle release reinforced by sublay mesh
Description: outcomes of complete burst abdomen repair using posterior component separation technique with transversus abdominis muscle release reinforced by sublay mesh
Study NCT03539237 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video demonstration of physical activity intensity levels
Description: In the video demonstration, an approximately 50 year old male explains 1) light-intensity, 2) moderate-intensity, and 3) vigorous-intensity physical activity referring to differences in heart rate, breathing frequency and capability to talk normally. Simultaneously, on a treadmill he demonstrates the body signs of the three intensity levels. He gives examples and points out that there are individual differences in the intensity evaluation of comparable activities.
Study NCT01072149 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone Furoate (FF)/GW642444 Inhalation Powder
Description: Inhaled Corticosteroid (ICS)/ Long Acting Beta Agonist(LABA) for COPD
Study NCT03982290 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo, microcrystalline cellulose
Description: Placebo capsules, 2 capsules per day
Study NCT02089919 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: cancer stem cell vaccine
Study NCT03812536 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No Void
Description: Currently the protocol at The Ohio State University Hospital requires voiding spontaneously prior to discharge from the PACU. Our intervention group will be discharged home without having to void spontaneously as a discharge criteria.
Study NCT04322188 — intervention group
Intervention type: OTHER
Description: this is an observational study. No intervention is applicable; patients are managed as per clinicians' best judgement and best practice
Study NCT03140397 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03140397 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 6-prenylnaringenin
Study NCT03140397 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 8-prenylnaringenin
Study NCT03482531 — intervention group
Intervention type: OTHER
Intervention: mathematical model
Description: mathematical model: regression equation that calculates the mean time from insert placement to delivery for each patient, based on every patient's characteristics (parity, BMI, cervical dilation and state of membranes)
Study NCT02735148 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Body Weight Supported Treadmill Training
Description: There were three intervention arms in this study,~1. Body Weight Supported Treadmill Training,~2. Conventional Training and~3. Combined Training.
Study NCT02493036 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SYN-010
Study NCT05663021 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided core needle biopsy in breast
Description: For patients who were not evaluated as progressive disease by the latest imaging measurement, repeated core needle biopsy is conducted within the baseline tattooed area after 2 to 4 cycles of neoadjuvant chemotherapy, depending on the total cycles of chemotherapy. Tissue is acquired from different sections of the lesion from different angles to minimize the impact of tumor heterogeneity. For each patient, 3 to 4 tissue specimens are collected and sent for pathological review to examine whether there is residual malignancy (residual cancer, pleomorphic tissue) in the tumor site that is tattooed.
Study NCT03294590 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: OHT Parent targeted text messages
Description: For the Oral health text message (OHT) group, the parent targeted text messaging program will include two core topics and a menu of options to choose from, all of which pertain to oral health.
Study NCT03294590 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CWT Parent targeted text messages
Description: For the CWT group, the parent targeted text messaging program will include two core topics and a menu of options to choose from, all of which pertain to child wellness.
Study NCT03232346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vivitrol
Description: Oral naltrexone induction procedure followed by Vivitrol
Study NCT03232346 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Description: 5-week buprenorphine taper
Study NCT04601012 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Optical coherence tomography angiography
Description: Each subject underwent optical coherence tomography angiography to evaluate the retinal vessel density.
Study NCT02686385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisolone
Study NCT02686385 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N-Acetylcysteine
Description: NAC (N-Acetylcysteine) dosing-Loading dose: 150 mg/kg IV; mix in 200 mL of 5% dextrose in water (D5W) and infuse over 1 h Dose 2: 50 mg/kg IV in 500 mL D5W over 4 h Dose 3: 100 mg/kg IV in 1000 mL D5W over 16 h
Study NCT02686385 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine
Description: NAC (N-Acetylcysteine) dosing-Loading dose: 150 mg/kg IV; mix in 200 mL of 5% dextrose in water (D5W) and infuse over 1 h Dose 2: 50 mg/kg IV in 500 mL D5W over 4 h Dose 3: 100 mg/kg IV in 1000 mL D5W over 16 h
Study NCT00411749 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (V501)
Description: V501; Gardasil, 0.5 ml injection in 3 dosing regimen
Study NCT00411749 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Comparator: Placebo (unspecified)
Description: Placebo 0.5 ml injection in 3 dosing regimen
Study NCT03187132 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital Pain Reduction Kit
Description: A two-component intervention consisting of (1) virtual reality, experiences lasting 3-30 minutes used to distract individuals from pain and to teach skills related to chronic pain; (2) TENS unit, used to reduce acute localized pain.
Study NCT03187132 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Control
Description: An active control TENS unit used to reduce acute localized pain.
Study NCT02178761 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: drug-eluting balloon
Description: angioplasty completed with drug-eluting balloons
Study NCT02178761 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: biodegradable vascular scaffold stent
Description: Stenting with biodegradable vascular scaffold stents
Study NCT02178761 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Apex™ PTCA Dilatation Catheter
Description: plain old balloon angioplasty alone
Study NCT02178761 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Stent System
Description: stenting with either bare-metal stents or drug-eluting stents
Study NCT01225094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: curcumin
Description: Patients will take the study medication (500 mg x 4 capsules, twice daily \[BID\]) for two days leading up to repair, totaling 4000 mg per day. They will take a dose (2000 mg) the morning of repair, at the same time as regular medications not held for surgery. While they are on call to the operating room, they will take another dose of 2000 mg and then another 2000 mg dose 6 hours after the repair. Final dose is administered the morning after repair.
Study NCT01225094 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: The placebo will look, smell, taste, and in every way be identical to the active drug. Patients will take the study medication in the exact same manner as the curcumin regimen.
Study NCT04006093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban Oral
Description: one Tablet 5mg
Study NCT01509755 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: Once daily injection, under the skin (s.c.) for 12 weeks
Study NCT01509755 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Once daily injection, under the skin (s.c.) for 12 weeks
Study NCT01509755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: liraglutide
Description: Once daily injection, under the skin (s.c.) for 12 weeks
Study NCT01509755 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: glimepiride
Description: Tablets administered orally according to current treatment guidelines. Dose adjusted according to the glycaemic response
Study NCT04210674 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The traditional medicinal product of Argan spinosa oil
Description: All children were randomly divided into two groups to receive either the traditional medicinal product of Argan spinosa oil or The conventional topical steroid ointment.
Study NCT04210674 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The traditional medicinal product of Argan spinosa oil
Description: All children were randomly divided into two groups to receive either the traditional medicinal product of Argan spinosa oil or The conventional topical steroid ointment.
Study NCT02098798 — intervention group
Intervention type: PROCEDURE
Intervention: HD Colonoscopy
Description: High definition colonoscopy procedure in surveillance colonoscopy
Study NCT02098798 — intervention group
Intervention type: PROCEDURE
Intervention: HD Colonoscopy + iSCAN
Study NCT02098798 — intervention group
Intervention type: PROCEDURE
Intervention: HD Colonoscopy + dye spray
Study NCT02634333 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Prompt Sham
Description: A sham injection (syringe without a needle pressed against the injection site) is performed on the day of randomization and visits at 1, 2, and 4 months and then every 4 months thereafter.
Study NCT02634333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prompt aflibercept
Description: Intravitreal injection of 2.0mg aflibercept is performed on the day of randomization and visits at 1, 2, and 4 months and then every 4 months thereafter.
Study NCT02634333 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Deferred laser
Description: Laser (either focal/grid laser for diabetic macular edema or panretinal photocoagulation for proliferative diabetic retinopathy) is added following initiation of anti-vascular endothelial growth factor injections for center-involved diabetic macular edema or proliferative diabetic retinopathy only if certain criteria are met
Study NCT02634333 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Deferred laser
Description: Laser (either focal/grid laser for diabetic macular edema or panretinal photocoagulation for proliferative diabetic retinopathy) is added following initiation of anti-vascular endothelial growth factor injections for center-involved diabetic macular edema or proliferative diabetic retinopathy only if certain criteria are met